Baltijos medicinos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 48,310 | 73,643 | 50,623 | 46,339 | 45,476 | 48,217 | 41,381 | 42,579 |
| Profit before tax | -7,420 | -4,466 | 52 | 3,890 | 2,344 | 9,927 | -11,091 | -12,207 |
| Net profit | -7,420 | -4,466 | 32 | 3,633 | 2,231 | 9,433 | -11,091 | -12,207 |
| Equity | -18,587 | -23,053 | -23,021 | -19,388 | -17,157 | -7,724 | -18,815 | -31,022 |
| Liabilities | 110,132 | 146,513 | 125,828 | 118,701 | 129,401 | 191,437 | 177,558 | 186,131 |
| Non-current assets | 24,701 | 45,030 | 26,391 | 11,964 | 12,260 | 56,597 | 73,674 | 69,739 |
| Current assets | 66,713 | 78,430 | 76,416 | 87,197 | 99,984 | 125,822 | 87,009 | 88,037 |
| Total assets | 91,414 | 123,460 | 102,807 | 99,161 | 112,244 | 182,419 | 160,683 | 157,776 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,905 | - | 6,674 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -17.2% | +52.4% | -31.3% | -8.5% | -1.9% | +6.0% | -14.2% | +2.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.1% | -3.6% | 0.0% | 3.7% | 2.0% | 5.2% | -6.9% | -7.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -15.4% | -6.1% | 0.1% | 7.8% | 4.9% | 19.6% | -26.8% | -28.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -15.4% | -6.1% | 0.1% | 8.4% | 5.2% | 20.6% | -26.8% | -28.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,883 | 24,548 | 16,874 | 15,446 | 15,159 | 16,072 | 13,794 | 14,193 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Baltijos medicinos centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-02-19 | 2024-02-20 | 107.40 |
Baltijos medicinos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-08-28 | 2025-08-28 | 598.53 |
| 2025-08-22 | 2025-08-27 | 161.53 |
| 2025-07-28 | 2025-07-29 | 75.53 |
| 2025-04-28 | 2025-04-28 | 104.47 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Baltijos medicinos centras, UAB (code 302756469) is a Private Limited Liability Company operating in other non-specialised retail sale. In the latest financial year, 2025, revenue reached €42.6K, rising 2.9% year on year from €41.4K in 2024, but remaining below €48.2K in 2023. Net profit was -€12.2K in 2025, following a loss of -€11.1K in 2024 after a profit of €9.4K in 2023, which indicates a clear weakening in profitability over the three-year period. The 2025 profit margin was -28.7%, and return on assets was -7.7%. Total assets amounted to €157.8K, compared with €160.7K in 2024 and €182.4K in 2023. Equity stayed negative and fell to -€31.0K, while liabilities increased to €186.1K from €177.6K a year earlier. Long-term assets were €69.7K and short-term assets €88.0K. Asset turnover was 0.27x, showing limited revenue generation relative to the asset base. Revenue per employee was €14.2K and profit per employee was -€4.1K. Negative equity means return and leverage ratios should be interpreted cautiously.